These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10155675)

  • 21. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.
    Bate CM; Green JR; Axon AT; Murray FE; Tildesley G; Emmas CE; Taylor MD
    Aliment Pharmacol Ther; 1997 Aug; 11(4):755-63. PubMed ID: 9305486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine 300 mg twice daily and 150 mg four-times daily are effective in healing erosive oesophagitis.
    Silver MT; Murdock RH; Morrill BB; Sue SO
    Aliment Pharmacol Ther; 1996 Jun; 10(3):373-80. PubMed ID: 8791966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia.
    Kaplan-Machlis B; Spiegler GE; Zodet MW; Revicki DA
    Arch Fam Med; 2000 Jul; 9(7):624-30. PubMed ID: 10910310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
    Maton PN; Orlando R; Joelsson B
    Aliment Pharmacol Ther; 1999 Jun; 13(6):819-26. PubMed ID: 10383513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.
    Carlsson R; Galmiche JP; Dent J; Lundell L; Frison L
    Aliment Pharmacol Ther; 1997 Jun; 11(3):473-82. PubMed ID: 9218069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
    Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P
    Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
    Wiklund I; Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir D; Fulton C; Gillon K; Peacock R
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):19-27. PubMed ID: 9615259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment.
    Annibale B; Franceschi M; Fusillo M; Beni M; Cesana B; Delle Fave G
    Hepatogastroenterology; 1998; 45(21):742-51. PubMed ID: 9684126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ranitidine for erosive oesophagitis: a double-blind, placebo-controlled study. Glaxo Erosive Esophagitis Study Group.
    Roufail W; Belsito A; Robinson M; Barish C; Rubin A
    Aliment Pharmacol Ther; 1992 Oct; 6(5):597-607. PubMed ID: 1420751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice.
    Dakkak M; Jones BP; Scott MG; Tooley PJ; Bennett JR
    Br J Clin Pract; 1994; 48(1):10-4. PubMed ID: 8179973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease.
    Revicki DA; Sorensen S; Maton PN; Orlando RC
    Dig Dis; 1998; 16(5):284-91. PubMed ID: 9892788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.
    Bardhan KD; Morris P; Thompson M; Dhande DS; Hinchliffe RF; Jones RB; Daly MJ; Carroll NJ
    Gut; 1990 Jul; 31(7):745-9. PubMed ID: 2370010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
    Dent J; Yeomans ND; Mackinnon M; Reed W; Narielvala FM; Hetzel DJ; Solcia E; Shearman DJ
    Gut; 1994 May; 35(5):590-8. PubMed ID: 8200548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Aliment Pharmacol Ther; 1988 Jun; 2(3):221-7. PubMed ID: 2979246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial.
    Havelund T; Laursen LS; Skoubo-Kristensen E; Andersen BN; Pedersen SA; Jensen KB; Fenger C; Hanberg-Sørensen F; Lauritsen K
    Br Med J (Clin Res Ed); 1988 Jan; 296(6615):89-92. PubMed ID: 3122967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis.
    Eggleston A; Wigerinck A; Huijghebaert S; Dubois D; Haycox A
    Gut; 1998 Jan; 42(1):13-6. PubMed ID: 9505878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
    Dammann HG; Blum AL; Lux G; Rehner M; Riecken EO; Schiessel R; Wienbeck M; Witzel L; Berger J
    Dtsch Med Wochenschr; 1986 Jan; 111(4):123-8. PubMed ID: 3510847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
    Ofman JJ; Yamashita BD; Siddique RM; Larson LR; Willian MK
    Am J Manag Care; 2000 Aug; 6(8):905-16. PubMed ID: 11186502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.